Skip to main content

Table 2 Rotavirus-related events or costs with and without rotavirus vaccine and averted outcomes with vaccination, (lower limit, upper limit)

From: Comparison of impact and cost-effectiveness of rotavirus supplementary and routine immunization in a complex humanitarian emergency, Somali case study

  Without vaccine With RI Averted by vaccine % reduction With SIA Averted by vaccine % reduction
No. of events        
 Deaths 3,864 2,956 (1,478-4,434) 908 (454–1,362) 23.5 3,504 (1,752-5,257) 359 (180–539) 9.3
 Cases 606,917 499,251 (374,438-624,064) 107,665 (80,749-134,582) 17.7 564,309 (423,232-705,386) 42,608 (31,956-53,260) 7.0
 Receive care 100,961 81,203 (60,902-101,504) 19,758 (14,818-24,697) 19.6 93,142 (69,857-116,428) 7,819 (5,864-9,774) 7.7
 Number of DALYs 197,683 151,308 (76,236-226,381) 46,375 (23,313-69,437) 23.5 179,331 (90,323-268,338) 18,353 (9,226-27,479) 9.3
 DALYs averted per 1000 children    109 (55–163)    43 (22–65)  
Medical treatment costs (US$) 322,618 258,825 (194,119-323,532) 63,793 (36,067-79,741) 19.8 297,372 (223,029-371,716) 25,246 (18,934-31,557) 7.8
Vaccination program costs (US$) -- 309,458 (126,309-726,279) -- -- 715,713 (261,292-942,923) -- --
Net costs (medical plus vaccination campaign, US$) -- 568,283 (385,135-985,104) -- -- 1,013,085 (558,664-1,240,295) -- --